ZNTL Latest Press Releases

-- November 3, 2026 --

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences Globe Newswire 4:15 PM

-- November 2, 2026 --

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:00 PM

-- October 23, 2026 --

Zentalis Pharmaceuticals Announces Meaningful Median Overall Survival Data in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer from DENALI Part 1b to be Presented at the ESMO Congress 2026 Globe Newswire 10:15 AM

-- October 18, 2026 --

Zentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstract Globe Newswire 6:05 PM

-- October 1, 2026 --

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:10 PM

-- September 2, 2026 --

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- September 1, 2026 --

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:15 PM

-- August 17, 2026 --

Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:01 PM

-- August 13, 2026 --

Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering Globe Newswire 10:23 PM

Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering Globe Newswire 4:01 PM

-- August 6, 2026 --

Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates Globe Newswire 4:05 PM

-- August 3, 2026 --

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:00 PM

-- July 17, 2026 --

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026 Globe Newswire 4:15 PM

Market Data Delayed 15 Minutes